For example, higher levels of SPARC expression have been reported in breast cancer [6], [7], hepatocellular carcinoma [8], [9], prostate cancer [10], colorectal cancer [11], [12], and ovarian cancer [13], [14]. This evidence concerns the gene SPARC and prostate cancer.